BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 33121471)

  • 21. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.
    Gillen DL; Meyskens FL; Morgan TR; Zell JA; Carroll R; Benya R; Chen WP; Mo A; Tucker C; Bhattacharya A; Huang Z; Arcilla M; Wong V; Chung J; Gonzalez R; Rodriguez LM; Szabo E; Rosenberg DW; Lipkin SM
    Cancer Prev Res (Phila); 2015 Mar; 8(3):222-30. PubMed ID: 25604134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats.
    Shpitz B; Bomstein Y; Kariv N; Shalev M; Buklan G; Bernheim J
    Int J Colorectal Dis; 1998; 13(4):169-72. PubMed ID: 9810521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of colorectal cancer: Past, present, and future.
    Umezawa S; Higurashi T; Komiya Y; Arimoto J; Horita N; Kaneko T; Iwasaki M; Nakagama H; Nakajima A
    Cancer Sci; 2019 Oct; 110(10):3018-3026. PubMed ID: 31361372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
    Mohania D; Kansal VK; Kruzliak P; Kumari A
    Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
    Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
    BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
    Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
    Sehdev A; O'Neil BH
    Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histomorphology of aberrant crypt foci in colorectal carcinoma.
    Norlida AO; Phang KS
    Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
    Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
    Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
    Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
    Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
    BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci.
    Kowalczyk M; Siermontowski P; Mucha D; Ambroży T; Orłowski M; Zinkiewicz K; Kurpiewski W; Paśnik K; Kowalczyk I; Pedrycz A
    PLoS One; 2016; 11(2):e0148286. PubMed ID: 26886097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.